Skip to main content
NCBI home page
Canadian Medical Association Journal logoLink to Canadian Medical Association Journal
. 1975 Feb 8;112(3):331–335.

Some aspects of medical management of gastrointestinal disease. Part II *

Bernard W D Badley
PMCID: PMC1956331  PMID: 20312630

Abstract

Antacids are among the most frequently used drugs, yet common prescribing habits suggest that there is little familiarity with effective dosage schedules, side effects, or the differences between various antacid preparations. These factors, which are important in the choice of a specific antacid preparation, are discussed in an attempt to provide a rational basis for therapy.

Corticosteroids, salicylazosulfapyridine (Salazopyrin) and diphenoxylate hydrochloride-atropine (Lomotil) are often used in treatment of inflammatory bowel disease. Recently described regimens for treating acute exacerbations and maintaining remission in patients with ulcerative colitis are reviewed, and attention is drawn to possible adverse effects of Lomotil in the treatment of colonic disease.

Full text

PDF
331

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. BARMAN M. L., LARSON R. K. THE EFFECT OF GLYCOPYRROLATE ON NOCTURNAL GASTRIC SECRETION IN PEPTIC ULCER PATIENTS. Am J Med Sci. 1963 Sep;246:325–328. doi: 10.1097/00000441-196309000-00011. [DOI] [PubMed] [Google Scholar]
  2. BARON J. H., CONNELL A. M., LENNARD-JONES J. E., JONES F. A. Sulphasalazine and salicylazosulphadimidine in ulcerative colitis. Lancet. 1962 May 26;1(7239):1094–1096. doi: 10.1016/s0140-6736(62)92080-9. [DOI] [PubMed] [Google Scholar]
  3. Barreras R. F. Acid secretion after calcium carbonate in patients with duodenal ulcer. N Engl J Med. 1970 Jun 18;282(25):1402–1405. doi: 10.1056/NEJM197006182822504. [DOI] [PubMed] [Google Scholar]
  4. Baume P. E., Hunt J. H. Failure of potent antacid therapy to hasten healing in chronic gastric ulcers. Australas Ann Med. 1969 May;18(2):113–116. doi: 10.1111/imj.1969.18.2.113. [DOI] [PubMed] [Google Scholar]
  5. Blumenthal I. S. Digestive disease as a national problem. 3. Social cost of peptic ulcer. Gastroenterology. 1968 Jan;54(1):86–92. [PubMed] [Google Scholar]
  6. Buchman E., Kaung D. T., Dolan K., Knapp R. N. Unrestricted diet in the treatment of duodenal ulcer. Gastroenterology. 1969 Jun;56(6):1016–1020. [PubMed] [Google Scholar]
  7. Dissanayake A. S., Truelove S. C. A controlled therapeutic trial of long-term maintenance treatment of ulcerative colitis with sulphazalazine (Salazopyrin). Gut. 1973 Dec;14(12):923–926. doi: 10.1136/gut.14.12.923. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. DuPont H. L., Hornick R. B. Adverse effect of lomotil therapy in shigellosis. JAMA. 1973 Dec 24;226(13):1525–1528. [PubMed] [Google Scholar]
  9. EDWARDS F. C., TRUELOVE S. C. THE COURSE AND PROGNOSIS OF ULCERATIVE COLITIS. Gut. 1963 Dec;4:299–315. doi: 10.1136/gut.4.4.299. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Fordtran J. S., Morawski S. G., Richardson C. T. In vivo and in vitro evaluation of liquid antacids. N Engl J Med. 1973 May 3;288(18):923–928. doi: 10.1056/NEJM197305032881801. [DOI] [PubMed] [Google Scholar]
  11. Goldberg H. I., Dodds W. J., Gee S., Montgomery C., Zboralske F. F. Role of acid and pepsin in acute experimental esophagitis. Gastroenterology. 1969 Feb;56(2):223–230. [PubMed] [Google Scholar]
  12. Goligher J. C., Hoffman D. C., de Dombal F. T. Surgical treatment of severe attacks of ulcerative colitis, with special reference to the advantages of early operation. Br Med J. 1970 Dec 19;4(5737):703–706. doi: 10.1136/bmj.4.5737.703. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Jalan K. N., Prescott R. J., Sircus W., Card W. I., McManus J. P., Falconer C. W., Small W. P., Smith A. N., Bruce J. An experience of ulcerative colitis. II. Short term outcome. Gastroenterology. 1970 Oct;59(4):589–597. [PubMed] [Google Scholar]
  14. LAWRENCE J. S. Dietetic and other methods in the treatment of peptic ulcer. Lancet. 1952 Mar 8;1(6706):482–485. doi: 10.1016/s0140-6736(52)90052-4. [DOI] [PubMed] [Google Scholar]
  15. LENNARD-JONES J. E., BABOURIS N. EFFECT OF DIFFERENT FOODS ON THE ACIDITY OF THE GASTRIC CONTENTS IN PATIENTS WITH DUODENAL ULCER. I. A COMPARISON BETWEEN TWO 'THERAPEUTIC' DIETS AND FREELY-CHOSEN MEALS. Gut. 1965 Apr;6:113–117. doi: 10.1136/gut.6.2.113. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. LENNARD-JONES J. E., LONGMORE A. J., NEWELL A. C., WILSON C. W., JONES F. A. An assessment of prednisone, salazopyrin, and topical hydrocortisone hemisuccinate used as out-patient treatment for ulcerative colitis. Gut. 1960 Sep;1:217–222. doi: 10.1136/gut.1.3.217. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. LENNARD-JONES J. E., MISIEWICZ J. J., CONNELL A. M., BARON J. H., JONES F. A. PREDNISONE AS MAINTENANCE TREATMENT FOR ULCERATIVE COLITIS IN REMISSION. Lancet. 1965 Jan 23;1(7378):188–189. doi: 10.1016/s0140-6736(65)90973-6. [DOI] [PubMed] [Google Scholar]
  18. McMillan D. E., Freeman R. B. The milk alkali syndrome: a study of the acute disorder with comments on the development of the chronic condition. Medicine (Baltimore) 1965 Nov;44(6):485–501. doi: 10.1097/00005792-196511000-00002. [DOI] [PubMed] [Google Scholar]
  19. Oakley G. P., Jr The neurotoxicity of the halogenated hydroxyquinolines. A commentary. JAMA. 1973 Jul 23;225(4):395–397. [PubMed] [Google Scholar]
  20. Pittman F. E. Letter: Adverse effects of Lomotil. Gastroenterology. 1974 Aug;67(2):408–410. [PubMed] [Google Scholar]
  21. Pittman F. E., Westphal M. C. Optic atrophy following treatment with diiodohydroxyquin. Pediatrics. 1974 Jul;54(1):81–83. [PubMed] [Google Scholar]
  22. Rhodes J., Apsimon H. T., Lawrie J. H. pH of the contents of the duodenal bulb in relation to duodenal ulcer. Gut. 1966 Oct;7(5):502–508. doi: 10.1136/gut.7.5.502. [DOI] [PMC free article] [PubMed] [Google Scholar]
  23. SUN D. C. LONG-TERM ANTICHOLINERGIC THERAPY FOR PREVENTION OF RECURRENCES IN DUODENAL ULCER. Am J Dig Dis. 1964 Oct;9:706–716. doi: 10.1007/BF02237730. [DOI] [PubMed] [Google Scholar]
  24. Sprinz H. Pathogenesis of intestinal infections. Arch Pathol. 1969 Jun;87(6):556–562. [PubMed] [Google Scholar]
  25. TRUELOVE S. C., WATKINSON G., DRAPER G. Comparison of corticosteroid and sulphasalazine therapy in ulcerative colitis. Br Med J. 1962 Dec 29;2(5321):1708–1711. doi: 10.1136/bmj.2.5321.1708. [DOI] [PMC free article] [PubMed] [Google Scholar]
  26. TRUELOVE S. C., WITTS L. J. Cortisone in ulcerative colitis; final report on a therapeutic trial. Br Med J. 1955 Oct 29;2(4947):1041–1048. doi: 10.1136/bmj.2.4947.1041. [DOI] [PMC free article] [PubMed] [Google Scholar]
  27. Truelove S. C., Jewell D. P. Intensive intravenous regimen for severe attacks of ulcerative colitis. Lancet. 1974 Jun 1;1(7866):1067–1070. doi: 10.1016/s0140-6736(74)90552-2. [DOI] [PubMed] [Google Scholar]
  28. Wruble L. D., Duckworth J. K., Duke D. D., Rothschild J. A. Toxic dilatation of the colon in a case of amebiasis. N Engl J Med. 1966 Oct 27;275(17):926–928. doi: 10.1056/NEJM196610272751704. [DOI] [PubMed] [Google Scholar]

Articles from Canadian Medical Association Journal are provided here courtesy of Canadian Medical Association

RESOURCES